Everest Medicines (01952) has announced the establishment of an Environmental, Social and Governance Committee, effective from September 28, 2026.
The ESG Committee shall consist of no fewer than three members.
The Board has appointed Mr. Wu Yifang, Mr. Luo Yongqing, Ms. Wang Yue, and Mr. Li Yifan as members of the Environmental, Social and Governance Committee.
Mr. Wu Yifang has also been appointed as the Chairman of the Environmental, Social and Governance Committee.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments